Frequently Asked Questions
Who is required to file a Beneficial Ownership Information (BOI) report under the CTA?
Most businesses, including corporations, LLCs, LLPs, and other entities formed by filing with a Secretary of State, must file a BOI report unless they qualify for an exemption. Exempt entities include publicly traded companies, banks, credit unions, insurance companies, securities brokers, and large operating companies with over 20 full-time employees, an operating presence in the U.S., and sales exceeding $5 million.
What information must be included in a BOI report?
A BOI report must include details about the entity's beneficial owners, defined as individuals who own or control 25% or more of the entity or exercise substantial control. Required information for each beneficial owner includes their name, date of birth, address, and a photograph of a government-issued ID.
What are the deadlines for filing a BOI report?
Entities formed before January 1, 2024, must file their initial BOI report by January 1, 2025. Entities created on or after January 1, 2024, must file their BOI report within 90 days of formation. Additionally, any changes to the reported information must be updated within 90 days.
Under the Corporate Transparency Act (CTA)
Beginning January 1, 2024, the Corporate Transparency Act (CTA) imposed new disclosure requirements on businesses. The CTA requires most businesses to report information about the owners of the business to the Treasury’s Financial Crimes Enforcement Network (FinCen). Below are some of the highlights of this new law.
The CTA requires corporations, LLCs, LLPs and other entities formed by filing a document with a Secretary of State to file a Beneficial Ownership Information (BOI) report with FinCEN, unless the entity qualifies for an exemption. Entities that are not exempt from the CTA are called “domestic reporting companies”.
There are many different types of businesses that are exempt from filing under the CTA. Most of these exemptions apply to businesses that already have significant federal or state reporting obligations. Entities that are exempt include publicly traded companies, banks, credit unions, insurance companies and securities brokers. There is also an exemption for large operating companies that (i) have more than 20 full-time employees, (ii) have an operating presence in the U.S., and (iii) have sales exceeding $5 million.
For entities created before January 1, 2024, the BOI report must include information about the business and its beneficial owners. For entities created on or after January 1, 2024, the BOI report must also include information about the entity’s applicants.
The BOI report must include certain information about the entity’s “beneficial owners”. Beneficial owners include anyone who, directly or indirectly, either owns or controls 25% or more of the entity or who exercises substantial control over the entity. The information reported to FinCEN for each beneficial owner must include their name, date of birth, address and a photograph of a government issued ID.
For entities formed before January 1, 2024, the initial BOI report must be filed by January 1, 2025. For entities formed after January 1, 2024, the initial BOI report must be filed with 90 days of the entity’s creation. If the information reported on a BOI report changes, an updated report must be filed with 90 days.
MORE ARTICLES BY CATEGORY
Texas Moves to Rein in Ketamine Therapy—And Other States are Likely Next
The regulatory environment surrounding ketamine therapy is entering a new phase of maturity and enforcement. Recently, the Texas Medical Board published proposed regulations governing ketamine therapy, one of the first comprehensive regulatory frameworks in the country.
Read More >>California Hospice Fraud Crackdown: What it Means for Providers & How to Protect Your Business
California’s hospice fraud crackdown is only the beginning of what CMS and Medi-Cal regulators have claimed will be many more cases brought against hospice facilities and home health agencies. Providers who do not timely respond to a suspension or revocation may waive important rights. Act now to protect your business and reputation from governmental overreach based on data mining and other unreliable sources.
Read More >>New Executive Order Signals Faster Psychedelic Drug Approvals--and Closer DEA Scrutiny
On Saturday, April 18, President Trump signed an executive order designed to accelerate federal drug approvals for psychedelic drugs, a move experts are calling a significant win for patient access. But for ketamine providers and practices offering ketamine-assisted psychotherapy (KAP), increased coordination among regulators means increased scrutiny is inevitable. In this article, we break down what this executive order means for the future of regulatory enforcement.
Read More >>The WISeR Model: A New Era of Prior Authorization and Audit Risks for Wound Care
On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) officially launched the Wasteful and Inappropriate Service Reduction (WISeR) Model. This initiative is not just another administrative hurdle; it is a technology-driven enforcement overhaul aimed directly at the wound care industry.
Read More >>
